Skip to main content
. 2020 Dec 29;22(1):241. doi: 10.3390/ijms22010241
DLL4 Delta-like-ligand 4
VEGF Vascular Endothelial Growth Factor
VEGFR Vascular Endothelial Growth Factor Receptor
FDA Food and Drug Administration
PDX Patient-Derived Xenograft
CSC Cancer stem cell
scFv Single-chain Fv
IV Intravenous
MTD Maximum Tolerated Dose
DLT Dose-limiting Toxicity
AEs Adverse Events
SD Stable Disease
PR Partial Response
%TGI % Tumor Growth Inhibition
IACUC Institutional Animal Care and Use Committee
HCC Hepatocellular Carcinoma
NSCLC Non-Small Cell Lung Cancer